The same method was used for LC-MS analysis to identify m/z and fragmentation of maximum unknown impurities (Non-Pharmacopoeial) i.e. Impurity-I (1), Impurity-III (3), Impurity-V (5) and Impurity-VIII (9) formed during stability studies.
Also, the binding energy has two weaker symmetric local maxima for the impurity in the outer dots.
For this study, analytical grade hexanol containing the maximum limits of impurities of cyclohexanone (1.1 vol%), water (0.3 vol%) and the rest being traces of other foreign alcohols.
The binding energy has a maximum value when the impurity is located on the center of dots and decreases for other impurity positions.
For F=0 the binding energy has a maximum value when the impurity is located at the center of the inner dot.
In the case of Si-, N- and, P-doped systems, the FL moves to valence band maximum (VBM) and some impurity states are introduced between the VBM and the CBM.
In this case the variation of binding energy is not symmetric, it has only a maximum value when the impurity is located at the center of QD1. Figure 2 The variations of binding energy in terms of impurity position in the presence of electric fields.
The maximum allowed level of impurities in the drug substance is an important consideration.
Optimum operating treatment time was determined for maximum removal of these impurities by running the experiment for 24, 48 and 72 h, respectively.
Lg*, effective gate length; σ = σs + σd, sum of the standard deviations of interatomic distances in the S/D extensions; Ss, the maximum separation between neighboring impurities in the S extension; Sd, that in the D extension; S, that in the S/D extensions.
The factors are an effective gate length (Lg*), standard deviations of interatomic distances in the S/D extensions (σs and σd), their sum (σ = σs + σd), and the maximum separation between neighboring impurities in the S extension (Ss), in the D extension (Sd), and in the S/D extensions (S).
